Cargando…
Triple action Pt(iv) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistance
A series of triple action Pt(iv) prodrugs was designed to test the hypothesis that multi-action compounds, where each bioactive moiety intervenes in several cellular processes, might be more effective than a single agent at killing cancer cells. In particular, “triple action” Pt(iv) derivatives of c...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Royal Society of Chemistry
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944384/ https://www.ncbi.nlm.nih.gov/pubmed/29780561 http://dx.doi.org/10.1039/c8sc00428e |